The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
from NYT > Health https://ift.tt/u8YFsQG
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment